Related Experiment Video
Updated: May 29, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Fracture risk assessment in patients with chronic kidney disease
S A Jamal1, S L West, P D Miller
1Department of Medicine, University of Toronto, Toronto, ON, Canada. sophie.jamal@utoronto.ca
Insights
Fractures are common in chronic kidney disease (CKD) patients, especially those on hemodialysis. Current bone density tests are limited for predicting fractures in CKD, necessitating new assessment methods.
Area of Science:
- Nephrology
- Orthopedics
- Metabolic Bone Disease
Background:
- Patients with chronic kidney disease (CKD) experience high rates of fractures, leading to significant morbidity and mortality.
- Bone mass measurements are standard for fracture risk in the general population, but their effectiveness in CKD patients, particularly those on hemodialysis, remains uncertain.
Purpose of the Study:
- To review the epidemiology and causes of fractures in CKD patients, focusing on hemodialysis.
- To summarize existing data on fracture risk factors, including bone mass, mineral metabolism markers, and muscle strength, in CKD.
- To highlight the limitations of current bone density testing in CKD.
Main Methods:
- Literature review of studies on fractures in CKD patients.
- Analysis of data linking risk factors (bone mass, biochemical markers, muscle strength) to fractures.
- Evaluation of dual energy X-ray absorptiometry (DXA) and peripheral quantitative tomography (pQCT) utility in CKD.
Main Results:
- CKD patients fracture due to poor bone quantity, quality, and neuromuscular function.
- Evidence linking bone quality, turnover markers, and neuromuscular function to fractures in CKD is scarce.
- Bone mineral density testing has limited clinical utility for fracture prediction in CKD, especially in advanced stages (4 and 5).
Conclusions:
- Fractures in CKD are multifactorial, involving bone and muscle impairments.
- Current bone density measurements are inadequate for reliable fracture risk assessment in CKD patients.
- Further research is needed to develop noninvasive measures of bone strength for improved fracture risk prediction in CKD.
Abstract:
Fractures are common in patients with chronic kidney disease (CKD) and associated with substantially high morbidity and mortality. Bone mass measurements are commonly used to assess fracture risk in the general population, but the utility of these measurements in patients with CKD, and specifically among those on hemodialysis, is unclear. This review will outline the epidemiology and etiology of fractures in patients with CKD with a particular emphasis on men and women on hemodialysis. As well, we will summarize the published data, which describes the association between risk factors for fracture (including bone mass measurements, biochemical markers of mineral metabolism, and muscle strength) and fractures in patients with CKD. Patients with CKD suffer from fractures due to impairments in bone quantity, bone quality, and abnormalities of neuromuscular function. There is a paucity of evidence on the associations between bone quality, bone turnover markers, neuromuscular function, and fractures in patients with CKD. Furthermore, the complex etiology of fractures combined with the technical limitations of bone mineral density testing, both by dual energy X-ray absorptiometry (DXA) and by peripheral quantitative tomography (pQCT), limits the clinical utility of bone mass measurements for fracture prediction in CKD; this is particularly true among patients with stages 4 and 5 CKD. Further prospective studies to identify noninvasive measures of bone strength that can be used for fracture risk assessment are needed.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury III: Clinical Manifestations

